Mycological testing in Australasian clinical mycology laboratories: survey of the current state and access to testing

Keyphrases

• Diagnostic Methods 100%
• Australia 100%
• New Zealand 100%
• D-glucan 100%
• Laboratory Survey 100%
• Fungal Identification 100%
• Clinical Mycology 100%
• Access to Testing 100%
• Mycology Laboratory 100%
• Species Identification 50%
• Polymerase Chain Reaction 50%
• DNA Sequencing 50%
• Therapeutic Drug Monitoring 50%
• Clinical Laboratory 50%
• Whole Genome Sequencing 50%
• Infectious Disease Specialist 50%
• Fungal Pathogens 50%
• Molecular Assay 50%
• Microbiology Laboratory 50%
• Microscopy 50%
• Diagnostic Ability 50%
• One-site 50%
• Antifungal Resistance 50%
• Resistant Fungi 50%
• Antifungal Susceptibility 50%
• Antibody-antigen 50%
• Monitoring Resistance 50%
• Direct Detection 50%
• Laboratory Scientists 50%
• Tertiary Public Hospitals 50%
• Aspergillus Galactomannan 50%
• On-site Testing 50%
• Fungal Diagnosis 50%
• Institutional Characteristics 50%
• Public Health Facilities 50%
• Drug Resistance Surveillance 50%
• Resistance Surveillance 50%
• Antigen Detection 50%
• Mycological Diagnosis 50%
• Clinical Microbiologist 50%

Immunology and Microbiology

• Mould 100%
• Fungus Identification 100%
• Fungi 100%
• Polymerase Chain Reaction 50%
• DNA Sequence 50%
• Infectious Agent 50%
• Drug Resistance 50%
• Whole Genome Sequencing 50%
• Infectious Disease 50%
• Immune Complex 50%
• Aspergillus 50%
• Antifungal Resistance 50%
• Antifungal Susceptibility 50%
• Microbiology 50%
• Infection 50%

Medicine and Dentistry

• Glucan 100%
• Fungus Identification 100%
• Diagnosis 100%
• Infection 50%
• Aspergillus 50%
• Pathogen 50%
• Therapeutic Drug Monitoring 50%
• Polymerase Chain Reaction 50%
• Drug Resistance 50%
• DNA Sequence 50%
• Antifungal Resistance 50%
• Antigen Antibody Complex 50%
• Galactomannan 50%
• Whole Genome Sequencing 50%
• Antifungal Susceptibility 50%